These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28007378)

  • 1. Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis.
    Defourny N; Dunscombe P; Perrier L; Grau C; Lievens Y
    Radiother Oncol; 2016 Dec; 121(3):468-474. PubMed ID: 28007378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical review and quality-assessment of cost analyses in radiotherapy: How reliable are the data?
    Defourny N; Monten C; Grau C; Lievens Y; Perrier L
    Radiother Oncol; 2019 Dec; 141():14-26. PubMed ID: 31630866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National costs and resource requirements of external beam radiotherapy: A time-driven activity-based costing model from the ESTRO-HERO project.
    Defourny N; Perrier L; Borras JM; Coffey M; Corral J; Hoozée S; Loon JV; Grau C; Lievens Y
    Radiother Oncol; 2019 Sep; 138():187-194. PubMed ID: 31319281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost calculation: a necessary step towards widespread adoption of advanced radiotherapy technology.
    Lievens Y; Borras JM; Grau C
    Acta Oncol; 2015; 54(9):1275-81. PubMed ID: 26198650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatments for Metastatic Prostate Cancer (mPC): A Review of Costing Evidence.
    Norum J; Nieder C
    Pharmacoeconomics; 2017 Dec; 35(12):1223-1236. PubMed ID: 28756597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost evaluation to optimise radiation therapy implementation in different income settings: A time-driven activity-based analysis.
    Van Dyk J; Zubizarreta E; Lievens Y
    Radiother Oncol; 2017 Nov; 125(2):178-185. PubMed ID: 28947098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
    Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
    Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health economics in radiation oncology: introducing the ESTRO HERO project.
    Lievens Y; Grau C
    Radiother Oncol; 2012 Apr; 103(1):109-12. PubMed ID: 22325993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of radiotherapy in Sweden.
    Acta Oncol; 1996; 35 Suppl 6():57-71. PubMed ID: 9154086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it?
    van Loon J; Grutters J; Macbeth F
    Lancet Oncol; 2012 Apr; 13(4):e169-77. PubMed ID: 22469127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The cost of radiotherapy].
    Martin P
    Bull Cancer; 2003 Nov; 90(11):969-75. PubMed ID: 14706900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Economic evaluation of radiotherapy: methods and results].
    Durand-Zaleski I
    Cancer Radiother; 2005 Nov; 9(6-7):449-51. PubMed ID: 16219481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncology.
    Olchanski N; Zhong Y; Cohen JT; Saret C; Bala M; Neumann PJ
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):931-40. PubMed ID: 26478989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness studies in radiation therapy.
    Sher DJ
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):567-82. PubMed ID: 20950072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Health-economic aspects of radiotherapy].
    Vandemaele M; Lievens Y
    Rev Med Liege; 2024 May; 79(S1):117-122. PubMed ID: 38778659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced topics in evidence-based urologic oncology: economic analysis.
    Vogel B; Gilbert SM; Boylston Herndon J; Dahm P
    Urol Oncol; 2011; 29(4):454-61. PubMed ID: 21726796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring the cost of palliative radiotherapy.
    Warde P; Murphy T
    Can J Oncol; 1996 Feb; 6 Suppl 1():90-4. PubMed ID: 8853544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013.
    Amin NP; Sher DJ; Konski AA
    Appl Health Econ Health Policy; 2014 Aug; 12(4):391-408. PubMed ID: 25022451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of burn care: a systematic review.
    Hop MJ; Polinder S; van der Vlies CH; Middelkoop E; van Baar ME
    Wound Repair Regen; 2014; 22(4):436-50. PubMed ID: 25041616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.